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ABSTRACT

The purpose of this study was to establish the effect of an acute bout of moderate and
vigorous aerobic exercise on production of the inflammatory cytokine interleukin-6 (IL6) and the acute phase protein C-reactive protein (CRP). Ten male recreationally trained
cyclists (average age 30.3 ± 5.7 years) completed two 40-minute cycling bouts on two
separate occasions. A moderate-intensity exercise bout was performed at 50% of V02max
and a vigorous-intensity exercise bout was performed at 80% of V02max, Blood samples
were taken before exercise, 30 minutes into exercise, and then 15, 30, 45, 60, 90, 120,
180, and 240 minutes post-exercise. Average percent of V02max for moderate and
vigorous exercise was 52.7 ± 1.6 and 76.8 ± 5.0 percent, respectively. There was a
significant increase in CRP during and following both moderate and vigorous exercise (p
< 0.05). IL-6 was increased 15-minutes after moderate exercise, and during and for I
hour following vigorous exercise (p < 0.05). The increase in IL-6 was greater following
vigorous compared to moderate exercise (p = 0.001). Change in IL-6 during vigorous
exercise was correlated with the change in CRP immediately following the exercise bout
(p = 0.003, r = 0.826). These results show that an acute bout of moderate or vigorous
exercise can result in an acute phase response during exercise. This acute phase response
is related to the inflammatory response that occurs during exercise.
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CHAPTER 1
INTRODUCTION
The American Heart Association recommends increasing physical activity as one
method for reducing heart attack risk.20 Acute bouts of physical activity, however, can
increase the risk for having a myocardial infarction (MI). 12 Vigorous physical exertion is
associated with an increased risk for MI and the risk for MI is higher with vigorous
i�tensity compared to moderate-intensity exercise. 1' 12• 45 A meta-analysis examining the
external triggers of MI found that the odds ratio for MI occurrence following heavy
physical activity was 6.21 (P < 0.001 ), whereas the odds ratio for MI with moderate
physical activity was 1.11 (P = 0.45). 12 The Myocardial Infarction Onset Study
investigated the relationship between physical exertion and risk of acute MI.45 Compared
to performing less strenuous or no physical activity, the relative risk for MI following
heavy physical exertion was 5.9. The average induction time for MI following heavy
exertion was within one hour. Undergoing heavy physical exertion 2 to 5 hours prior to
MI did not increase risk for MI. The Physician's Health Study also demonstrated a
significant increased risk for the occurrence of a cardiac event following or during
vigorous exertion. The relative risk for sudden death by cardiac causes during the one
hour period associated with vigorous exertion (30 minutes during and 30 minutes after)
was 16.9 (P < 0.001) compared to any other time point. 1 The primary cause of sudden
cardiac death following acute exertion is thought to be due to plaque rupture.6• 83 The
plaque rupture itself is not the exact cause of death, but the resulting platelet aggregation
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and thrombosis that is a result of this rupture is what leads to acute myocardial infarction
and sudden death.
Acute phase proteins and inflammatory cytokines may increase the risk for the
occurrence of a cardiac event. During a stress response, C-reactive protein (CRP) and
interleukin-6 (IL-6) enter into circulation. Once in circulation, the inflammatory
molecules may produce a larger inflammatory response in other areas of the body by
binding to sites such as fibrous caps present in atherosclerotic plaque. A higher
concentration of inflammatory molecules located at this site will increase the risk for the
cap to rupture, ultimately leading to vessel occlusion. 18• 69
An acute-phase response occurs during exercise in response to skeletal muscle
tissue damage. The first response to an exercise bout is the production of IL-6 in the
exercising skeletal muscle. 57 This local inflammatory response results in a systemic
reaction by stimulating additional IL-6 production in the liver and the release of CRP
from the liver into circulation.48• 52 CRP is an acute phase protein that serves both as a
pro-inflammatory and anti-inflammatory molecule. The purpose behind the initial
release of CRP is for this pro-inflammatory protein to initiate an inflammatory response
at the site of skeletal muscle damage. This inflammatory response that CRP and IL-6 are
responsible for consists of the regulation and the migration of neutrophils and monocytes
to the skeletal muscle to initiate repair. 48• 52
The earliest study showing an acute phase response to aerobic exercise was
performed by Liesen et al. 40 Eight male subjects performed 3 separate treadmill bouts: 2
hours at 90% of aerobic-anaerobic threshold speed, 3-hours at 75% of aerobic-anaerobic
2

threshold speed, and 2 hours at 75% of aerobic-anaerobic threshold speed. Blood
samples were taken before exercise, immediately after exercise, and 1, 2, 4, and 7 days
following exercise. The study found a significant increase in CRP from rest to day 1
following exercise after all three running bouts, demonstrating an acute phase response
within 24 hours of treadmill running.
A recent study by Scharhag et al. investigated the effect of moderate intensity
cycling on immune cell function in competitive male athletes. 64 Twelve highly-trained
men cycled for 4 hours on a 400 m track at 70% of their anaerobic threshold. Blood
samples were taken before, immediately after exercise, 1, 2, and 19 hours post-exercise,
and 1 day post-exercise. A significant increase in IL-6 occurred from before exercise
(1.0 ± 0.5 pg/ml) to I-hour post-exercise (9.6 ± 5.6 pg/ml). CRP increased significantly
from before exercise (0.5 ± 0.4 mg/I) to I-day post-exercise (1.8 ± 1.3 mg/1). A
significant correlation was found between CRP and IL-6 over the exercise day (r = 0. 71,
p < 0.01). This study was able to demonstrate an acute phase response to moderate
prolonged cycling, with almost a 10-fold increase in IL-6 and a 3- to 4-fold increase in
CRP in well-trained competitive athletes.
Plaisance et al. sought to determine the inflammatory response to a single bout of
moderate-intensity exercise. 60 Ten high-fit and 11 low-fit males performed treadmill
exercise at 70% ofV02max to expend 500 kcals. Blood samples were taken 2 consecutive
days before and then 24, 72, and 120 hours post-exercise. No significant changes
occurred in CRP following the exercise bout in either group. Although no changes were
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seen 24-hours post-exercise, this study failed to determine if any immediate inflammatory
response may have occurred following aerobic exercise.
A study that did measure CRP values immediately following an exercise bout was
performed by Miles et al. 44 CRP and IL-6 were measured in men and women following a
20-mile off-road race. Blood samples were collected 0, 4, and 24 hours post-race. CRP
levels were highest 4-hours post-race (women: 1.3 ± 1.9 to 2.7 ± 2.3 mg/I; men: 0.8 ± 0.8
to 4.6 ± 1.6 mg/1), with no significant gender by time interaction. This study does show
an immediate inflammatory response, however, the vigorous nature and the long duration
of the exercise bout would make it difficult to generalize the results to more normal
exercise.
Henson et al. looked at the acute-phase response in 15 elite rowers (average
V02max 4.1 ± 0.08 L/min) from the ARCO Olympic Training Center. 29 All women
performed a 2-hour rowing session at moderate intensity (average 57% V02max), The
athletes did not participate in any physical activity 12 hours prior to the practice period.
Blood samples were taken pre-exercise, post-exercise, and 1.5-hr post-exercise. No
significant changes in CRP or IL-6 were observed, suggesting that extended bouts of
moderate exercise does not result in an increase in these inflammatory markers.
However, the elite status of these subjects, as well no control over activity in the 48 hours
prior to the study may have contributed to the lack of change in CRP and IL-6 following
this activity.
Hubinger et al. showed no inflammatory response to level and downhill treadmill
running. Subjects for this study averaged 20 years of age and participated in recreational
4

sport activities. The first part of the study had eight males perform I hour of level
treadmill running at 90% HR.max· The second part of the study had three males and 3
females perform two 15-minute downhill runs, followed by one 10-minute downhill run
with 5 minute seated recovery between each bout (-15% decline grade). Blood samples
were taken immediately before, immediately after, and 1, 3, 5, and 7 days post-exercise.
No changes in CRP were found following either protocol. Although a blood sample was
taken immediately following the exercise bouts, there was no attempt to determine the
inflammatory response in the immediate few hours following the exercise. Because of a
potential lag time in release between IL-6 and CRP, an elevation in CRP directly
following the exercise may not be expected, but may have occurred in the hours
following.
Nieman et al. had women who reported walking at least 2 to 5 days per week
perform a moderate walking bout at 60% of V02max for 30 minutes.53 IL-6 levels
immediately following and I-hr post-exercise were significantly higher than pre-exercise
values (P < 0.001). There was no difference between IL-6 levels measured immediately
post- and I-hour post-exercise. CRP was not analyzed in this study, so the effect of a
moderate walking bout on this acute-phase protein is still unknown. The increase in IL-6
following the walking bout, however, did show that moderate intensity exercise can result
in an inflammation response in some individuals.
Lack of consistency in this area makes it difficult to draw conclusions regarding
the effects of a single aerobic exercise bout on the acute-phase response, primarily the
production of CRP. Most studies were designed to investigate changes over a period of
5

days, failing to look at the hours immediately following the exercise bout. With CRP
having a half-life of 19 hours, any change in this inflammatory marker within a few hours
following exercise may not be captured if a sample is not taken until 24-hours post
exercise. Without studies sampling the first few hours following an exercise bout, one
cannot determine if the aerobic exercise results in an immediate elevated inflammatory
state and acute phase response.

Purpose
The optimal intensity of activity to decrease risk for cardiac events, but provide
optimal health benefit is currently not known. There is debate surrounding the optimal
intensity for prescribing exercise, with many feeling that vigorous exercise must be
incorporated into daily physical activity. However, since vigorous activity leads to a
greater risk for the onset of MI compared to moderate activity, a better understanding of
the inflammatory response that may be responsible for triggering a MI should be
established. Therefore, the purpose of this study is to characterize the inflammatory
response, with regards to IL-6 and CRP production, during and immediately following
moderate and vigorous exercise.

Hypotheses
1. There will be a significant increase in IL-6 following moderate-intensity activity.
2. There will be no change in CRP following moderate-intensity exercise.
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3. There will be a significant increase in CRP and IL-6 following vigorous-intensity
exercise.
4. The increase in IL-6 will be significantly greater following vigorous-intensity
exercise compared to the increase measured with moderate-intensity exercise
5. A positive relationship will exist between changes in CRP and changes in IL-6
following vigorous exercise.
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CHAPTER2
REVIEW OF LITERATURE
Interleukin-6
Interleukin-6 (IL-6) is a pro-inflammatory cytokine produced by lymphocytes,
monocytes, fibroblasts, vascular smooth muscle cells, and endothelial cells. The release
of IL-6 is stimulated by interleukin- I (IL-1) and tumor necrosis factor-� (TNF-p).46• 50
IL-6 can have a direct effect on the inflammation response by stimulating the hepatic
acute phase response, macrophage production, platelet aggregation, proliferation of
vascular smooth muscle cells, and expression of adhesion molecules and additional
cytokines in endothelial cells. 22' 26• 32' 33• 49' 5 1
When tissue injury occurs, either by infection or non-infectious causes, the body
reacts using a local inflammatory response. This response includes the release of the pro
inflammatory cytokine IL-6, which further activates the vascular system and release of
more inflammatory cells. 75 The additional cytokines and inflammatory cells then
circulate throughout the bloodstream and are responsible for activating a systemic
reaction.25 As part of this systemic reaction, circulating IL-6 stimulates the acute phase
response, resulting in the release of the acute phase protein C-reactive protein (CRP). 27

Acute Phase Response and C-Reactive Protein
The acute phase response is a systemic reaction caused by infection, injury, or
trauma. 23• 24 During the acute phase response cytokines stimulate the release of acute
phase proteins including CRP, serum amyloid A (SAA), and haptoglobin (Hp) from
8

hepatocytes.27• 28 11-6 is the major mediator responsible for the secretion of acute phase
proteins, predominantly CRP. 27
CRP is an acute-phase protein that serves both as a pro-inflammatory and an anti
inflammatory molecule. In the pro-inflammatory state, the main function of CRP is to
work as a protective mechanism by targeting pathogens and marking them for cellular
destruction. In the anti-inflammatory state, CRP works to neutralize anti-inflammatory
cytokines, proteases, and oxidants released during an inflammatory response to tissue
damage.
In the pro-inflammatory state, CRP is capable of recognizing and targeting cells
for destruction. CRP can target foreign pathogens and the phospholipid component of
damaged cells by binding to phosphocoline. In normal functioning healthy cells, CRP is
unable to bind to phosphocoline. However, when cells are in a damaged or dead state,
this site becomes accessible, allowing CRP to bind to and target these molecules for
destruction. 78 The elimination of targeted cells can also be initiated by CRP because of its
ability to activate the complement system and bind to phagocytic cells, both important
components of the host defense mechanisms. 78 Finally, CRP also functions in the pro
inflammatory state to modulate the function of monocytes by binding to and stimulating
the release of inflammatory cytokines such as IL-I, IL-6, and IL-8 in addition to tumor
necrosis factor. 3
The anti-inflammatory functions of CRP have been studied extensively in mice
and show the protective function that CRP may play in the inflammation process. These
findings can be applied to the inflammation response in humans because of the use of
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CRP transgenic mice. In terms of CRP, these mice react in the same manner as a human
because they have been given the 31-kb fragment of human DNA that contains the CRP
gene, 50-and 30-flanking DNA encoding for the CRP promoter, and all of the known
CRP gene regulatory elements. 9 By using CRP transgenic mice, Heuertz et al. was able
to show that CRP is capable of inhibiting the adhesion of neutrophils to endothelial cells.
This was found using the mouse model, in which higher CRP levels led to reduced lung
injury by functioning to inhibit the influx of neutrophils into the lungs. 30 In addition to
this study using mice, human model research has found that superoxide production by
neutrophils is also inhibited by CRP. 5 This finding adds to the combined effects that
CRP has on neutrophils to down-regulate the acute inflammatory response. 5

Sources of Inflammatory Markers with Exercise
Previous research has provided evidence of an inflammatory response to aerobic
exercise. 53 • 65• 68• 76 There is, however, conflicting evidence over what stimulates the
production of inflammatory markers during and following an exercise bout. Possible
sources include skeletal muscle, circulating mononuclear cells, or other body tissues. 65
The production of the inflammatory cytokine IL-6 directly within skeletal muscle has
been demonstrated following an acute bout of exercise.4• 57 Skeletal muscle responds to
an exercise bout by locally producing cytokines including IL-6, TNF-a, and IL-1� . This
local inflammatory response results in a systemic reaction by releasing additional IL-6
from the liver and initiating an acute phase response by stimulating the production of
CRP. 48• 52 The newly formed CRP and IL-6 are then available to circulate through the
10

body and bind to damaged membranes and proteins to initiate or continue an
inflammatory response. The inflammatory response that CRP and IL-6 are responsible
for consists of the regulation and the migration of neutrophils and monocytes to the
muscle to initiate repair.47' 52
Two early studies out of the Copenhagen Muscle Research Center investigated
the inflammatory response to exercise by looking at IL-6 production in skeletal muscle
and its relation to muscle damage following an exercise bout.4• 5 7 Ostrowksi et al. used
muscle biopsy samples before and after the Copenhagen Marathon to determine whether
IL-6 was produced locally in exercising skeletal muscle following strenuous exercise. 57
Sixteen trained males, average age of 30 years and average V02max of 4.36 Umin,
completed the Copenhagen Marathon. Muscle biopsies from the vastus lateralis of the
quadriceps femoris and blood samples were taken in 16 men 1 week prior to the race,
immediately following the race, and 2 hours post-race. Subjects refrained from exercise
2 days before the initial sample was taken one week before the race. Average running
time for all participants was 3 hours and 17 minutes. Plasma IL-6 increased from pre
(1.5 ± 0.7 pg/ml) to post-exercise (94.4 ± 12.6 pg/ml), and although still greater than pre
race levels, declined 2 hours after the race (22.1 ± 3.8 pg/ml). Muscle biopsy results
revealed no detectable mRNA for IL-6 pre-exercise, but four biopsies immediately post
race, and two biopsies 2 hours after the race detected IL-6 mRNA. There was no mRNA
for IL-6 detected in blood mononuclear cells. Creatine kinase ( CK) levels were still
greater one (2360 U/1) and two (1193 U/1) days post-race compared to pre-race levels
(225 U/1). The finding of IL-6 in the muscle but not in the blood mononuclear cells
11

(BMNC) suggests that IL-6 was locally produced in skeletal muscle in response to
muscle damage and repair.
Bruunsgaard et al. studied the relationship between cytokine production and
muscle damage in concentric versus eccentric exercise.4 Nine men, average age 26 years
and average V02max of 51.1 ml/kg/min were studied. All men were recreationally active
and participated in exercise 1-5 days per week for 1-2 hours. The exercise protocol for
this study included 30 minutes of concentric or eccentric cycling. The concentric cycling
included normal cycling at 65% of V02max, The eccentric cycling protocol had subjects
pedal in a reverse direction, at a predetermined speed, for 20 minutes at 150% followed
by 10 minutes at 100% of the load eliciting concentric VOimax, Blood samples were
taken before, 2 hours after, and 2, 4, and 7 days following each cycling bout. Subjects
were instructed not to perform any organized physical exercise for the 7 days after the
cycling exercise. The results of this study found that IL-6 increased significantly 2-hours
after the eccentric cycling compared to baseline levels, but not following the concentric
cycling. Creatine kinase (CK) was also significantly elevated following the eccentric
cycling at days 2, 4, and 7 compared to baseline levels. The authors chose to examine the
relationship between IL-6 and CK by using the mean of days 4 and 7 since they did not
know the exact peak value reached. There was a significant correlation (r = 0.722; p =
0,028) between IL-6 and CK following the eccentric cycling bout.
In contrast to those discussed above, some studies have found no association
between muscle damage and inflammation, and therefore have proposed that other
mechanisms are responsible for the increase in inflammatory markers found with
12

exercise. 1 1 • 55• 56• 7 1 Jonsdottir et al. studied IL-6 production in rat skeletal muscle
following eccentric and concentric exercise. 36 The study sought to determine whether the
type of contraction, using eccentric contractions to produce skeletal muscle damage
versus using concentric contractions without muscle damage, differed in terms of this
cytokine response. Rat calf muscle was electronically stimulated at 100 Hz ( 4 x 10
contractions with 1 minute rest between the four series) for concentric or eccentric
contractions. IL-6 mRNA was measured 30 minutes following contractions using reverse
transcription-polymerase chain reaction (RT-PCR). The study found a significant
increase in skeletal muscle IL-6 mRNA following both eccentric and concentric
contractions, showing that cytokine mRNA is produced locally in the contracting skeletal ·
muscle. The authors concluded that the similar increases in IL-6 mRNA found with both
contractions indicate that IL-6 production is not due to muscle damage primarily seen
with eccentric exercise, but was a result of muscle contraction. In addition to these
results, measurements taken in the contralateral hind limb that was not stimulated showed
no increase in the level of IL-6 mRNA. Also, the study found no difference in IL-6
mRNA increase between muscle fiber types.
A study looking at circulating levels of IL-6 from blood sampling, and not that
measured through muscle biopsy, showed no relationship between changes in IL-6 and
CK following treadmill running. 59 Peake et al. had 10 well-trained runners and triathletes
perform 45 minutes of treadmill running at a negative 10% grade at 60% V02max· Blood
samples were taken immediately before exercise, immediately following exercise, 1 hour
post-exercise, and 24 hours post-exercise. The study found a significant increase in
13

plasma IL-6 immediately following exercise, and remained elevated only at 1 hour post
exercise, before returning to baseline levels at 24 hours post-exercise. Plasma CK levels,
measured as a marker of muscle damage, were significantly increased at 24 hours post
exercise. However, there was no relationship between changes in IL-6 and changes in
CK with exercise.
The earlier studies concluded that the increase in IL-6 was due solely to
resulting muscle damage because the studies found increases in IL-6 and CK with
eccentric exercise but not concentric exercise. However, studies showing an increase in
IL-6 with concentric aerobic exercise provided evidence of an inflammatory response
without significant skeletal muscle damage. It has therefore been concluded that there
must be another mechanism for increased IL-6 production with exercise. 84 These other
sources, including circulating mononuclear cells,67 increased catecholamine production,
16• 66 • 74
61

and exercise induced ischemia causing cytokine release from the splachnic bed,2•

have all been found to be very minimal, and are not thought of as important sources of

exercise-induced cytokine release. 65
Although the exact mechanisms behind increased IL-6 production have not been
established, it is known that aerobic exercise does result in increased circulation of this
inflammatory cytokine. 65 The increase in IL-6 with acute exercise could then stimulate
the following responses: acute phase reaction, HPA axis, and xanthine oxidase expression
in the endothelium.
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Inflammatory Response to Exercise
Research available on inflammatory response following aerobic exercise, with
regards to increasing circulating levels of IL-6, has been consistent in its findings, with
significant increases occurring immediately following exercise. 1• 53• 68• 76 Nieman et al.
studied the immune response to a 30-minute bout of walking. 53 Fifteen women between
the ages of 20 and 55 who had a history of walking at least 20-30 minutes, 2-7 days per
week, for at least the previous 3 months were included in the study. The study was
designed to test the immune response to a 30-minute walk with and without an exercise
assist device (Body Bat). Both treadmill tests were performed at the same speed, which
corresponded to 60% of V02max· Women also underwent a control day where they sat for
30 minutes. Blood samples were taken 15 minutes prior to exercise or sitting,
immediately following, and 1 hour post-exercise or sitting. There was no difference in
IL-6 response with and without the Body Bat. Both treadmill tests had significantly
different changes in IL-6 values compared to sitting. IL-6 levels were significantly
greater than pre-walk values both immediately following and 1-hour post exercise for
both treadmill bouts, therefore showing an inflammatory response to a moderate bout of
exercise.
Vassilakopoulos et al. compared the cytokine response to aerobic exercise before
and after antioxidant supplementation.76 Six untrained males, average age 33 years,
cycled for 45 minutes at 70% of V02max on two separate occasions. Cycling bouts were
performed before and after 60 days of antioxidant supplementation. Antioxidant
supplementation included 200 mg of vitamin E, 50,000 IU of vitamin A, and 1,000 mg
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vitamin C daily for 60 days, allopurinol 600 mg per day for 15 days, N-acetylcysteine 2 g
per day for 3 days, and 800 mg on the morning before the second exercise bout. Subjects
refrained from exercise or strenuous activity 24 hours prior to both testing days. Blood
samples were taken before, immediately after, and 30 and 120 minutes following
exercise. IL-6 was increased immediately following exercise and reached its peak 30
minutes post-exercise. Although still greater than resting levels, the IL-6 response
following antioxidant supplementation was significantly lower compared to the exercise
response before supplementation. These results led the authors to conclude that oxidative
stress is a strong stimulator of cytokine production during exercise in healthy untrained
men.
Starkie et al. also showed an increase in IL-6 production following cycling
exercise. Seven endurance trained males cycled for 90 minutes at 70% of V02pea1c at
either 15° C or 35°C. 68 Blood samples were collected pre-exercise, 45 minutes into
exercise, immediately post-exercise, and 2 hours post-exercise. The study found a
significant increase in IL-6 immediately following exercise at 35° C but no increases
occurred with exercise at l 5 ° C. The authors speculated that exercising in heat may have
led to an increase in intramuscular glycogen use, which exacerbated IL-6 production in
the skeletal muscle.
These studies have established that an inflammatory response is initiated
following moderate and vigorous exercise. This response has also been found to occur in
both trained and untrained individuals. An increase in IL-6 following a single bout of
exercise, would make this inflammatory cytokine more readily available in circulation.
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As already established, IL-6 could then continue a systemic inflammatory response by
stimulating the production of additional inflammatory cytokines and by initiating an
acute phase response.

Acute Phase Response to Exercise in Laboratory Studies
The time course for the stimulation of the acute phase response varies, and can
occur within the first few hours of infection.25 Studies have been able to establish that an
acute phase response does occur following an acute bout of aerobic exercise, 37 however,
the time course of this response following exercise is unknown. The shortest time period
in which a significant increase in CRP has been shown, occurred immediately following a
short bout of maximal aerobic exercise. 1 9 The studies discussed in this section have
measured the release of CRP following varying exercise durations and intensities and
used different blood sampling periods, therefore making it difficult to characterize
specifically the acute phase response to exercise.
The earliest study demonstrating an acute phase response to aerobic exercise was
performed by Liesen et al.40 The study included eight male subjects, ages 2 1 to 29 years.
Blood samples were collected before, immediately after, and 1, 2, 4, and 7 days following
exercise. Exercise bouts included a 3-hour treadmill run or two 2-hour treadmill runs .
Running speed for the first 2-hour test was at 90% of aerobic-anaerobic threshold speed.
Average running speed for the 3-hour and second 2-hour test was 75% of the aerobic
anaerobic threshold speed. All running bouts resulted in a significant increase in CRP
from rest to 1 day following exercise. This led the authors to conclude that an acute
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phase response does occur within 24 hours following exercise in response to different
running durations and intensities.
A more recent study by Scharhag et al. studied the effect of moderate intensity
cycling on immune cell function in competitive male athletes. 64 Twelve men, average
age of 26 years, who had been cycling for 6.5 years and had trained on average 11 hours
per week during their season participated in the study. The men cycled for 4 hours on a
400 m track at 70% of their anaerobic threshold. Blood samples were taken immediately
before exercise, immediately after exercise, 1,.2, and 19 hours post-exercise, and 1 day
post-exercise. All men also underwent a control day in which blood samples were taken
at the same time points. There were no significant changes in IL-6 and CRP over the
control day. A significant increase in IL-6 occurred from before exercise (1.0 ± 0.5
pg/ml) to I-hour post-exercise (9.6 ± 5.6 pg/ml). CRP increased significantly from
before exercise (0.5 ± 0.4 mg/1) to I-day post-exercise (1.8 ± 1.3 mg/1). A significant
correlation was found between CRP and IL-6 over the exercise day (r = 0.71, p < 0.01).
This study was able to demonstrate that an acute phase response to moderate prolonged
cycling, with almost a IO-fold increase in IL-6 and a 3- to 4-fold increase in CRP, does
occur in well-trained competitive athletes.
The inflammatory and acute phase response to a 5-km run was studied by Drenth
et al. 1 7 Ten competitive runners (3 females, 7 males), age 17-36 years, completed the
running event. Average run time was 20.5 ± 1.5 min and average exercise intensity was
94% of heart rate reserve. Blood samples were taken immediately before, immediately
after, and 3, 24, and 48 hours after the run. CRP was significantly greater 24-hours after
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the run compared to baseline (p = 0.0 1 5) and then declined to baseline levels by 48hours. IL-6 was only detected in 2 of the 1 0 subjects. The IL-6 levels immediately
following the race were 20 pg/I and 1 8 pg/I for the two runners. Although IL-6 is the
principal stimulator of CRP, this study found a 1 .5-fold increase in CRP, but no
detectable changes in IL-6. The authors believe that the immunoassay may have been too
insensitive to detect significant changes in IL-6, therefore, making it difficult to draw any
conclusions about the IL-6 and CRP association following a 5-km run.
Sacheck et al. sought to determine whether age had an effect on the inflammatory
and acute phase response to exercise. 63 Sixteen physically active young men (1 8-35
years of age) and 1 6 elderly men (65-80 years of age) participated in the study. Subjects
performed 45 minutes of downhill treadmill running at 75% of V02rnax· Running was
done in three 1 5-minute intervals with a 5-minute rest period between each interval.
Blood samples were taken before exercise, immediately following exercise, and at 6, 24,
and 72 hours post-exercise. In both young and elderly men, CRP was approximately 2fold higher 24 hours following exercise (p < 0.00 1). IL-6 was increased in both groups at
6-hours post-exercise, but returned to baseline levels by 24-hours. There was also a
significant correlation (r2 = 0.3 1 , p < 0.0 1 ) between IL-6 and CRP at 24-hours. The
authors concluded that a bout of eccentric exercise can result in a similar acute phase
response in both young and elderly men.
A study designed to test the acute immune response to exercise performed at
different ambient temperatures was carried out using laboratory treadmill running. 54
Seven men who were competitive runners performed two separate 60-minute treadmill
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bouts at 75% of V02max. Running bouts were performed at temperatures of 18°C and
28° C. Subjects were told to refrain from vigorous training 5 days prior to the first run
and between runs. Blood samples were taken before, immediately after, and 30 minutes,
3 hours, 24 hours, and 48 hours after the end of each run. There was no difference in IL6 or CRP response between temperatures. IL-6 was significantly greater immediately
following and 30 minutes post-exercise compared to pre-exercise values. There was no
change in CRP at any time following exercise. These men trained on average 9 hours per
week and had an average V02max of 66.3 ml/kg/min. Therefore, highly trained runners
may experience an inflammatory response to running at a vigorous intensity for 60
minutes, however, this response may not be great enough to initiate an acute phase
response.
Hubinger et al. studied the response of acute phase reactants to both level and
downhill grade treadmill running.3 1 The first portion of the study included eight males,
ages 17 to 19 years, whose activity level included participating solely in weekend
recreational sports. Subjects performed I-hour of level treadmill running at a speed that
elicited 90% of maximal heart rate (HRmax). The second portion of the study included
males and females, 21 years of age, who again participated only in weekend recreational
sport activities. These subjects performed a downhill treadmill protocol chosen because
it was known to induce skeletal muscle damage. The running protocol for this portion of
the study included two 15-minute and one 10-minute downhill runs, with a 5-minute
seated recovery between each run. Runs were performed at a 15% negative incline and at
a speed eliciting 75-80% of HRmax · Subjects for both study portions had been fasted for
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1 2 hours and refrained from alcohol and exercise for 48 hours prior to testing. Blood
samples for both tests were taken before, immediately after exercise, and then 1 , 3, 5, and
7 days after testing. Subjects were told not to exercise during the 7-day period following
the run when blood samples were still being taken. There were no significant increases in
CRP at any of the sampling times for either running protocol. To note, CK levels were
significantly increased for both tests, with levels being highest 1 -day following both runs.
The authors concluded that neither treadmill protocol was able to produce significant
skeletal muscle injury and/or inflammation to induce an acute phase response.
The effect of fitness level on the inflammatory response to moderate exercise was
studied by Plaisance et al.60 Subjects included 1 0 high-fit (V02max = 53.9 ± 7.0
ml/kg/min; 29 ± 6 years of age) and 1 1 low-fit (V02max = 36.0 ± 5.0 ml/kg/min; 33 ± 8
years of age) males. Treadmill exercise included walking or jogging at 70% V02max to
expend a total of 500 kcals. Blood samples were taken two consecutive days before, and
24, 72, and 1 20 hours post-exercise. The study found no change in CRP during any of
the sampling times. Using results from this study one could conclude that both trained
and untrained individuals do not experience an acute phase response on the days
following vigorous treadmill exercise. However, the response was not measui;-ed within
the first 24-hours following exercise.
A study by Henson et al. tested the effect of carbohydrate beverage ingestion on
the inflammatory response to rowing.29 The study included 1 5 elite female rowers
training at the ARCO Olympic Training Center. At the time of the study, women were
averaging 1 2- 1 3 training sessions per week, with each session averaging 90- 1 20 minutes
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in length. The research design included three consecutive testing days: one baseline
sample day and two exercise days. On day 1, a blood sample was taken after a 9 hour
fast and subjects had not exercised in the previous 12 hours. On days 2 and 3, subjects
reported to the testing site following a 9 hour fast, and ingested either a carbohydrate or
placebo beverage. Subjects then performed a normal 2-hour training bout while
continuing to drink the respective beverage every 15 minutes. To determine exercise
intensity, all subjects wore a heart rate monitor and a subset of subjects had their V02
measured with a Cosmed K4 B-2 metabolic unit for a 10 minute period during exercise.
Blood samples were collected within 10 minutes following exercise and 1.5 hours
following exercise. During the 1.5 hours following exercise, subjects continued to drink
the carbohydrate or placebo beverage every 15 minutes. Subjects averaged 57% of
V02max during the 2-hour row. No differences in CRP or IL-6 were detected following
exercise. Results of this study showed that highly trained females do not experience an
acute pha�e response within the first 1.5 hours following moderate activity, regardless of
carbohydrate supplementation.
To date, studies have used a variety of exercise modes, durations, and intensities,
in an attempt to establish the inflammatory and acute phase response to a single bout of
aerobic exercise. An inflammatory response to exercise, regardless of intensity, has been
shown to occur within 60 minutes of aerobic exercise. 53• 64• 68' 76 An acute phase response
has also been found to occur within 24 hours of a vigorous-intensity exercise bout. 17• 40• 63•
64

However, additional studies using vigorous- or moderate-intensity exercise have failed

2
to see any inflammatory or acute phase response after an acute bout of aerobic exercise. 9•
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3 1 • 54• 60

Although IL-6 is the primary stimulator of the acute phase response, and some

studies have found an association between IL-6 and CRP following exercise,63 • 64
consistent evidence linking these markers of inflammation following moderate and
vigorous exercise has not been provided. A timeframe for IL-6 and CRP release
following an acute bout of moderate and vigorous exercise has also yet to be established.

Acute Phase Response to a Maximal Aerobic Test

Two studies have found conflicting results for the acute phase response
immediately following a maximal aerobic exercise test. 1 3 • 1 9 The use of aspirin therapy
on CRP release following a short maximal exercise bout was studied by Feng et al. 1 9
Thirty-two men, average age 29 ± 6 years, performed a Bruce maximal protocol test,
before and after 7 days of aspirin therapy. Blood samples were taken immediately before
and after the test. The study found no effect for aspirin therapy on CRP response. CRP
did significantly increase 1 3 percent from pre- (0.8 1 + 0. 1 3 mg/1) to post-test (0. 92 + 0. 1 3
mg/I)). The results showed that an individual can experience an acute phase response
immediately following a short maximal aerobic exercise bout, and that the use of anti
inflammatory medication does not attenuate this response.
In contrast to results found by the previous study, Czarkowska-Paczek et al. found
that an inflammatory response, but not an acute phase response, occurs following a
maximal aerobic power test. Fourteen trained male cyclists, average age 1 8 ± 0.5 years,
participated in the study. The average V02max for all participants was 65.7 ± 4.8
ml/kg/min. The exercise protocol included cycling on an exercise track until exhaustion.
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Participants cycled at 20 km/hr, while the grade of the track was increased every 3
minutes. Blood samples were taken before, immediately after, and 2 hours after exercise.
No significant change in CRP was detected over the 2 hours of sampling. IL-6 levels
immediately following (1.214 ± 0.566 pg/ml) and 2 hours post-exercise (10.071 ± 14.43
pg/ml) were significantly higher than pre-exercise levels (0.482 ± 0.309 pg/ml). There
was no correlation found between IL-6 and CRP levels following the exercise test. Using
only these findings, the authors concluded that IL-6 must not be the principal stimulator
of acute phase proteins in the liver following strenuous exercise, and that after this type
of activity it may only exert a metabolic effect and not an inflammatory or
immunological effect.
With lack of information regarding the fitness level of men in the Feng study, it is
difficult to draw any conclusions regarding the acute phase response to a maximal
aerobic power test. The average length of time of each test was also not provided, so it
can not be concluded that exercise duration was also a factor in stimulating an acute
phase response.

Acute Phase Response to Competitive Endurance Events

Additional studies have provided information regarding the acute phase response
to physical activity performed outside of a controlled laboratory setting. Although these
studies will be mentioned, the extreme nature of the physical activity in terms of duration
and intensity leads one to take discretion when generalizing the results to all populations
or to the acute phase response with more general exercise.
24

Byrne et al. studied the acute phase response following a 48-hour military
exercise (ME) in 200 military recruits. 8 All subjects had just completed a 10-week basic
training program prior to undergoing the final exercise. Six different groups provided
blood samples at different time points following the 48-hour exercise: group 1 at 12
hours, group 2 at 24 hours, group 3 at 48 hours, group 4 at 3 days, group 5 at 4 days, and
group 6 at 6 days. A significant increase in CRP concentration occurred in group 1 (12
hours), and a significant decrease in CRP was found in groups 5 ( 4 days) and 6 (6 days)
following the exercise bout. Lack of control over subjects' activity following the ME
may have had an effect on CRP levels found in groups whose samples were taken from
24 hours to 6 days post-exercise. The authors admit that CRP data may have been
compromised by undeclared exercise prior to the 48-hour exercise bout and intramuscular
injections, not described in detail by the authors, which were later found to have been
administered throughout the basic training program.
Strachan et al. sought to determine whether the extent of the acute phase response
to physical activity was dependent on running distance. 70 Thirty-eight volunteers from
five separate long distance races were studied. Pre- and post-race blood sampling times
were not the same for all races. Six runners from each event were studied following 15
and 21 km races. Blood samples taken before and 24 hours post-race showed a small
increase in CRP after both racing distances. Six runners had blood samples taken
immediately before, immediately after, and every 24 hours for 5 days following a 56 km
race. Compared to pre-race levels, CRP for this race was not increased immediately post
race but did reach the highest measured levels 1 day following the race. Twelve runners
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who completed the 88 km ultra-marathon had blood samples taken immediately before,
immediately after, and every 24-hours for 10 days following the race. CRP was elevated
immediately post-race, peaked by day 1, and then returned to pre-race levels by day 10.
Eight runners who ran a 42 km marathon had blood samples taken every three days for a
week preceding the race, immediately before, and immediately after the race. Additional
samples were taken every 12 hours for two days following the race, and then for 24 hours
for an additional 2 days. CRP was elevated immediately post-race, and then peaked 24
hours post-race. CK levels for all subjects were also analyzed to get a measure of tissue
injury for each racing distance. There was no correlation between CK and CRP
following any of the races. Exact values for CRP and CK were not provided by the
authors. Although the magnitude changes in CRP are not compared between different
events, the research does show an acute phase response to various running durations,
regardless of the extent of skeletal muscle damage.
The inflammatory response to a 32.3-kilometer trail race was measured in 27
male and female endurance-trained runners. 10 Runners who had run in at least three
previous ridge runs or at least 2 ridge runs and at least one ultra-endurance event were
grouped as experienced (n = 9). All other runners were grouped as novice (n = 18).
Average race time was 5. 9 ± 1.2 hours for experienced runners and 6.2 ± 1.3 hours for
novice runners. Blood samples were taken the afternoon before the race, and 0, 4, and
24-hours post-race. There was no difference in IL-6 response between groups, with a
significant increase occurring from pre- to immediately post-race. The novice group
increased from 0.93 ± 1.05 to 33.26 ± 23.94 pg/ml and the experienced group increased
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from 1.01 ± 0.55 to 32.22 ± 12.38 pg/ml. Both groups significantly increased CRP from
pre-race to 24-hours post-race (p < 0.001), with the experienced runners (2.15 ± 1.95 to
36.27 ± 27 .16 mg/1) having a significantly greater increase than the novice runners (0.69

± 0.73 to 14.91 ± 7.49 mg/1).

CK activity also increased at 0, 4, and 24 hours post-race.

The highest measured CK values occurred at 4-hours, with no difference in CK values at
anytime between groups. Although this study did show an extremely high increase in
CRP following this type of endurance event, correlations between CK and CRP were not
provided to determine if there was a relationship between skeletal muscle damage and the
inflammatory response.
A study by Miles et al. investigated the difference in CRP and IL-6 production in
men compared to women following a 20-mile race. 44 Blood samples were collected
from 8 men and 8 women 12-16 hours pre-race, and 0, 4, and 24 hours post-race.
Average running time for men and women were 6.0 ± 1.5 and 6.5 ± 1.2 hours,
· respectively. Males had a significantly greater (p < 0.05) increase in IL-6 than females,
with the greatest increase in both genders occurring from pre- to immediately post-race.
IL-6 in males increased from 0.7 ± 0.05 to 56.9 ± 45.6 pg/ml and increased in females
from 0.8 ± 0.7 to 27.0 ± 13.0 pg/ml. There was no effect for gender on CRP, with all
subjects having a similar increase in CRP from pre- to 4 hours post-race. CRP
concentrations increased from 0.5 ± 0.8 to 4.6 ± 1.6 mg/1 in men and 1.3

± 1.9 to 2.7 ±

2.3 mg/1 in women, showing a prominent acute phase response within the first few hours
following exercise. The study also measured CK levels following the race to determine
the extent of muscle damage. Results showed that the inflammatory response was not
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linked to changes in CK activity, which is consistent with other studies showing a lack of
relationship between muscle damage and the acute phase repsonse. 34• 59• 70
The relationship between gastro-intestinal complaints, cytokine release, and the
acute-phase response was studied in 1 female and 29 male triathletes following the
Ironman distance triathlon in Embrun, France. 34 The event consisted of a 3800 m swim,
185 km cycle ride, and a 42.2 km run. Blood samples were taken on the day prior to the
race, immediately after the race, and 1, 2, and 15-20 hours after the race. IL-6 was
increased 27-fold immediately following the race, and then decreased slowly thereafter,
although still staying greater than pre-race levels up to 2 hours following the race. IL-6
returned to pre-race levels 16 hours after the race. CRP concentration was significantly
elevated 2 hours after the race and reached an average of 30.2 ± 3.0 µg/ml 16-hours after
the race. There was a significant correlation between the highest IL-6 and CRP
concentrations (r = 0.442, p = 0.016), however, there was no correlation found between
CK and changes in CRP and IL-6. Using information provided by the athletes regarding
gastrointestinal complaints, it was found that CRP was associated with intestinal cramps
(r = 0.397, p < 0.05) and diarrhea (r = 0.511, p < 0.05) and IL-6 was associated with
vomiting (r = 0.268, p < 0.05) and diarrhea (r = 0.504, p < 0.05) following the race.
These results led the authors to conclude that endotoxemia, and potentially other
exercise-induced processes such as muscle damage, may be responsible for increased
cytokine acute-phase protein release following a long-distance triathlon.
Lechtermann et al. studied the inflammatory response to a marathon and 3
separate treadmill running bouts performed at different intensities and grades. 39
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Seventeen male runners of different training status performed a marathon run. Thirteen
male and female subjects performed three treadmill bouts: 80% of V02max, 60% of
V02max, and a downhill grade of negative 1 2% at 80% of V02max· No information
regarding time of treadmill runs or blood sampling was provided. The only results
provided for this study was that CRP levels were maximal the day after the marathon run.
Prolonged, vigorous endurance exercise has consistently shown an acute phase
response following exercise. Elevations in CRP were found immediately following
exercise,70 and within the first 24 hours following exercise. 8• 1 0•

3

4• 39• 44• 70

The

inflammatory response to these types of events was also extremely prominent
immediately following activity. 1 0• 34•

44

Risk for Myocardial Infarction with Physical Activity

The American Heart Association recommends increasing physical activity as one
method for reducing heart attack risk.20 Although the absolute risk for sudden cardiac
death or a cardiac event associated with physical activity is low, evidence is available
showing an increased risk for acute coronary syndromes with physical activity and heavy
physical exertion. 83 Data from the Physician's Health Study was used to determine the
risk of sudden death during, and within, 30 minutes of performing light or vigorous
physical exertion. 1 Subjects included 2 1 ,48 1 male physicians between the ages of 40 and
84, who were initially free from cardiovascular disease. Over the 1 2-year follow-up, 1 22
sudden deaths occurred that were attributable to cardiac causes. Information regarding
activity during time of death was obtained from medical records or next of kin, and was
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available for 80 percent of the men. Of all cardiac deaths, 1 3.9 percent occurred during
vigorous exertion and 4.9 percent occurred within 30 minutes after vigorous exertion.
Compared to any other time point surrounding the death, the relative risk for sudden
death occurring within 1 -hour of vigorous exertion was 1 6.9 (p < 0.00 1 , 95% CI 10.5 to
27.0).
Willi ch et al. investigated the risk of myocardial infarction (Ml) occurring with
strenuous physical exertion. 82 Information was gathered on 1 9 1 4 hospital patients who
were admitted with a primary diagnosis of acute MI. Patient interviews included
questions regarding medical history, physical activity, unusual life events, and location
and circumstances of the Ml. Age and sex matched controls (n = 532) were asked the
same interview questions as the MI patients, but were told to answer as if they h�d
experienced chest pain at a specific time provided by the interviewer over the past 24
hours. The specific times given to the control were distributed in a circadian pattern
identical to the times of MI onset of the MI patients. All physical activity was measured
and reported in terms of metabolic equivalents (MET). Compared to the control group,
the relative risk of a MI for those engaging in strenuous activity (2: 6 MET) was 1.9 (95%
CI 1.1 to 3.5). After adjusting for factors known to influence the risk of MI or factors
that differed between case and control subjects (hypertension, hyperlipidemia, diabetes,
smoking, previous MI, angina pectoris, use of cardiac drugs, current employment, age,
sex, and time of awakening), an independent relative risk of 2.1 (95% CI 1.1 to 3 .6) still
existed.
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Although the number of people suffering from a myocardial infarction following
exercise is low, the small excess risk can be detrimental for those who may already be
suffering from coronary artery disease. With an increased risk of a cardiac event being
shown with vigorous exercise, recommending moderate intensity activity may be the
safest in terms of exercise prescription. However, establishing the exact cause of MI
occurring with vigorous exercise may also help in decreasing the risk associated with this
intensity of exercise. Therefore, since the risk for MI is greatest during and within the
hours directly following vigorous activity, establishing what occurs with exercise that
leads to the occlusion of coronary arteries during this time frame is needed.

Triggering of an Acute Coronary Syndrome
Coronary plaque disruption is the primary mechanism by which atherosclerosis
results in an acute coronary syndrome. 21 Over 70% of all sudden deaths occurring with
exercise in people over the age of 35 years are attributed to the occlusion of coronary
arteries by platelet-rich thrombi. 15• 42 The main cause of plaque disruption is
inflammation.4 1 Activated inflammatory cells secrete proteinases that break down the
extracellular matrix. Although this process occurs for normal turnover of cellular tissue,
an imbalance in regulating this process can lead to pathological tissue destruction. For
example, breaking down the structural molecules of the extracellular matrix can lead to
weakening of the fibrous cap, making it more prone to rupture. The plaque disruption
causes platelet aggregation and thrombosis, resulting in unstable angina, acute
myocardial infarction, or sudden death. The actual plaque disruption is in reality an
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asymptomatic event, with the events following the plaque disruption, including
thrombosis and platelet aggregation, resulting in the clinical event. Studies have revealed
that 9% of normal healthy persons and 22% of individuals with diabetes or hypertension
have asymptomatic disrupted plaques, showin g that this potentially dangerous event may
occur more frequently than is recorded. 14
An increase in circulating CRP levels above an individual's normal concentration
may be one of the triggers of acute myocardial infarction, with higher circulating levels
of CRP resultin g in a destabilization of plaque. Recent evidence supports the idea that
CRP is involved in the process of plaque rupture by inducing endothelial cell
dysfunction.77 This process includes stimulating the production of matrix
metalloproteinase-1, inhibiting nitric oxide production, and inducing the upregulation of
chemokines and adhesion molecules at the site of plaque formation.58• 77
To determine if CRP may play a role in triggering acute coronary events, studies
have compared CRP levels following different acute conditions.7• 72• 85 Burke et al.
investigated the relationship between CRP and fatal coronary artery disease using
autopsy information from patients who died of sudden coronary death.7 Deaths were
classified as plaque rupture, plaque erosion, stable plaque, or control cases (unnatural
sudden death or non-cardiac death not related to elevated CRP). CRP was significantly
higher in deaths with plaque rupture (p < 0.0001 ), plaque erosion (p = 0.005), and stable
plaque (p = 0.0003) compared to controls. There was a significant association between
the degree of plaque burden (total amount of luminal narrowing in measured arterial
beds) and CRP (p = 0.03 ) .
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To determine whether CRP was associated with an increased risk for plaque
rupture or only atherosclerotic burden, Yip et al. measured CRP in patients following an
acute myocardial infarction ( AMI). 85 Their methodology was based on information
gathered by Tomoda and Aoki, who provided evidence that CRP measured within 6
hours of an AMI was representative of inflammatory activity prior to the AMI and not
inflammation as a result of myocardial damage. 73 Therefore, knowing that serum CRP
levels taken within 6 hours after the onset of an AMI offers information regarding
inflammatory activity at the time of plaque rupture,73 this study compared CRP measured
within and after 6 hours of onset of AMI symptoms. One hundred fifty-one patients had
blood samples taken within 6 hours after the onset of the AMI. Fifty-one patients had
blood samples taken greater than 6 hours, but less then 12 hours, following the onset of
an AMI. Additionally, 30 subjects who underwent a percutaneous coronary intervention
(PCI) following angina were used as coronary artery disease controls and 30 age- and
gender-matched volunteers were used as healthy controls. CRP was significantly higher
in patients with a measurement within 6 hours after AMI (2.7 ± 2.3 mg/I) compared to
patients with angina (1.4 ± 0.7 mg/I) and healthy controls ( 1.0 ± 0.6 mg/1). In patients
with measurements within 6 hours, there were significantly higher levels of CRP at
baseline in women, those with hypertension, and those without previous MI (p = 0.04).
The CRP levels were significantly higher in the 51 patients with measurements after 6
hours (14.1 ± 16.5 mg/I) compared to the 106 patients with measurements within 6 hours
(2.7 ± 2.3 mg/1). This study concluded that the higher levels of CRP in patients with
measurements greater then 6 hours reflected myocardial damage and the increased CRP
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in patients measured within 6 hours reflected the baseline CRP levels, or that at the onset
of the AMI. They also concluded that these two separate timeframes can show the
impact of CRP on atherosclerotic lesions as well as the response to an AMI. They
conclude that their results support that of Tomoda and Aoki,73 that a spike in CRP may be
a prerequisite for plaque rupture.
Tokac et al. concluded that CRP was directly involved in the triggering of an
acute coronary event.72 The study included 15 patients with stable angina pectoris (SAP),
16 patients with unstable angina pectoris (UAP), and 16 patients who had undergone
percutanious transluminal coronary angioplasty (PTCA). Blood samples were taken in
SAP patients 1 day after hospitalization and in UAP patients within 6 hours after onset of
pain and 12 hours following the first sample. Samples were taken from the PTCA
patients before the procedure and 2 and 14 hours after the procedure. Fifty-three of the
55 patients also underwent coronary angiography for determination of significant
coronary artery disease. CRP increased significantly in the UAP and PTCA groups.
UAP patients increased from 10.9 ± 7.2 mg/di within 6 hours of pain onset to 18.8 ± 14.9
mg/di at 12 hours after pain onset. PTCA patients had significantly higher CRP levels 14
hours after their procedure (24.5 ± 23.8 mg/di) compared to 2 hours after their procedure
(12.4 ± 6.4 mg/di). Both UAP and PTCA patients had significantly higher CRP levels at
6 hours after onset of pain and 2 hours after surgery, respectively, compared to CRP
levels in SAP patients after hospitalization (7.1 ± 5.6 mg/dl). The authors concluded that
the higher CRP levels in the UAP group compared to the SAP group, and the continual
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rise in CRP levels, showed that the increased inflammatory activity caused earlier plaque
rupture.
Both mechanistic and clinical studies have provided evidence that CRP may be a
culprit in triggering an acute coronary event. Although the exact levels of CRP that may
cause plaque rupture and a resulting coronary event are unknown, an inflammatory
response that causes a quick release of CRP in high concentration may result in plaque
rupture. With coronary plaque rupture being the primary cause of MI associated with
exercise, one could assume that an acute phase reaction in response to exercise may cause
a spike in CRP, leading to plaque rupture.

Conclusion
Physical activity is recommended in the treatment and prevention of
cardiovascular disease and is used as rehabilitation for those recovering from cardiac
complications. There is evidence however that vigorous physical activity increases the
risk for an acute coronary syndromes. The disrupting of plaque formations by CRP may
be one trigger for acute coronary syndromes. During an inflammatory response, IL-6
stimulates an acute phase reaction, resulting in the release of CRP from the liver. The
inflammatory response to exercise, which has been shown to result in the production of
IL-6, may stimulate a resulting acute phase response. Research available on the acute
phase response to exercise has reported varying results due to inconsistencies in
methodology. Studies investigating the inflammatory response to exercise more
consistent with physical activity recommendations have failed to examine the time period
35

directly following exercise, and instead has looked at subsequent days. These studies
have found an inflammatory response, but not necessarily a resulting acute phase
response. Because of a potential lag time in stimulation' of CRP release and then the
shorter half life of this protein, the time frames for sampling may have missed any acute
phase response that did occur. Research that h�s looked at the time period directly
following exercise has been performed on athletes competing in endurance events.
Although these studies have found an inflammatory and acute phase response following
exercise, the nature of the activity is more vigorous then most individuals would
undertake. Since the risk for death with exercise is greatest during and within the first
hour following activity, the acute phase response during this time period must be
established to determine whether this may play a role in triggering acute coronary
syndromes that occur with exercise. Since an inflammatory response has been found
with moderate-intensity activity, it should be established whether both moderate and
vigorous activity may put an individual at an increased risk for a coronary event.
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CHAPTER 3
METHODS
Subjects
Ten healthy, non-smoking, recreationally trained male cyclists, between the ages
of 1 8 and 40 were recruited for this study. Subjects were volunteers from the University
of Tennessee and surrounding community. Written informed consent, approved by the
University of Tennessee Institutional Review Board, was obtained prior to testing
(Appendix A). Subjects were included if they participated in vigorous cycle exercise at
least 4 days per week for greater than 30 minutes per day. A health history questionnaire
was completed (Appendix B). Height was measured using a stadiometer. Weight and
body composition were assessed by air displacement plethysmography using the Bod Pod
system (LMI, Inc., Concord, CA).

Maximal Oxygen Consumption
Subjects performed an incremental graded exercise test on a Lode Excalibur Sport
electronically braked cycle ergometer (Groningen, NL). Subjects were asked to choose a
self-selected cadence between 60 and 80 rpm. The test began with a 2-minute warm-up
at 50 watts. After two minutes the work rate was increased 25 watts per minute until
volitional fatigue. Respiratory gas exchange analysis was done using the TrueMax 2400
computerized metabolic system (ParvoMedics, Salt Lake City, UT). Before each test, 02
and CO2 analyzers were calibrated using gases of known concentrations, and the flow
meter was calibrated using a 3-L syringe. Heart rate was monitored using a Polar Heart
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Rate Monitor (Polar Electro Inc., Lake Success, NY), and was recorded every minute.
The test was considered maximal if two of the following criteria had been satisfied: 1) a
respiratory exchange ratio (RER) � 1.15, 2) heart rate within 15 beats per minute of age
predicted HRmax (220-age), and 3) leveling off in V02 despite an increase in work rate
(<150 ml·min· 1 increase between stages).

Moderate and Vigorous Cycling Bouts
Subjects performed a moderate and vigorous exercise bout on two different
occasions separated by 1-2 weeks. All testing began between 6am and 9am and subjects
started both testing days at the same time. Subjects were asked to refrain from all
exercise and alcohol consumption for 48 hours prior to testing. When subjects arrived at
the laboratory a venous catheter was placed into the forearm. The catheter was kept
patent with a sterile saline drip. After resting for 15 minutes, a baseline (B) blood sample
was taken.
V02 was monitored during exercise using the TrueMax 2400 metabolic system.
The moderate exercise bout was performed at 50% of V02max and the vigorous exercise
was performed at 80% of V02max· The subjects performed a 5-minute warm-up on the
cycle ergometer, during which time the work rate was gradually increased to a level
eliciting the pre-determined moderate or vigorous V02 . Subjects chose a comfortable
pedal speed between 60 and 80 rpm to maintain throughout the exercise bout. After the
5-minute warm-up, the subject continued to cycle at the same work load for 40 minutes.
The average V02 for each session was calculated by averaging the V02 values at each
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minute over the 40-minute period. Blood samples were taken 30 minutes into the cycle
bout (30) and O (0), 15 (+15), 30 (+30), 45 ( +45), 60 (+60), 90 (+90), 120 (+120), 180
(+180), and 240 minutes (+240) post-exercise.

Blood Samples
A 5 ml blood sample was obtained from a forearm vein during each sampling
period for determination of CRP and IL-6. Blood samples were collected into a serum
separator tube. Samples were centrifuged for IO minutes and serum was removed and
frozen fo� subsequent analysis.
All blood samples were stored and analyzed at the end of all testing at The
University of Tennessee Medical Center DynaCare Laboratories. Samples were kept at 80°C and returned to room temperature prior to running the analyses. Procedures for
running the hs-CRP (lmmulite 2000 High Sensitivity CRP, DPC) and IL-6 (lmmulite
2000 IL-6 EIA, DPC) assays were performed according to the manufacturer's guidelines.
All samples were run in duplicate.

Statistical Analysis
All statistical analyses were performed using SPSS Version 13.0 (SPSS Inc.,
Chicago, IL). A two-way repeated measures ANOVA (time x exercise intensity) was
used to compare the inflammatory response at different time-points following exercise.
A Pearson's Product Moment Correlation was used to see if there was a relationship
between CRP and IL-6 response following each exercise bout.
39

CHAPTER 4
RESULTS
Ten male participants completed both cycling bouts. Participant characteristics
are presented in Table 1. Average V02max for participants was 50.6 ± 7.1 ml/kg/min.
The average percentage of V02max maintained by participants for the moderate exercise
bout (52.7 ± 1.6 percent) was significantly lower (p < 0.001) than the average percent of
V02max maintained for the vigorous exercise bout (76.8 ± 5.0 percent).
There were no differences in baseline CRP and IL-6 values for participants
between the moderate and vigorous exercise days and between the first and second
testing days, regardless of intensity. CRP and IL-6 levels during and following exercise
are presented in Table 2. Compared to baseline levels, CRP was significantly higher
during, immediately following, and 15-minutes after the completion of the moderate
exercise bout (p < 0.05) (Fig. 1). CRP was significantly higher during and immediately
following vigorous exercise compared to baseline levels (p < 0.05) (Fig. 1). There was
an increase in IL-6 following moderate and vigorous exercise compared to baseline levels
(Fig. 2). IL-6 was increased during and for 1 hour following vigorous exercise, with the
highest level being measured 15-minutes post-exercise. IL-6 was increased 15 minutes
following moderate exercise, but the increase was not as large as the increase following
vigorous exercise for this same time point (p = 0.001).

40

Table 1. Baseline characteristics of participants (n = 10)
Mean ± SD
Measure
30.3 ± 5.7
Age ( y)
181.1 ± 5.2
Height (cm)
82.8' ± 5.9
Body mass (kg)
14.6 ± 9.6
Body fat (%)
50.6 ± 7.1
V02 max (ml/kg/min)
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Table 2. Comparison of CRP and IL-6 before, during, and after a bout of moderate and vigorous exercise (Mean± SE)
Immediate�
Before
post15 min post- 30 min post- 45 min postMeasure
During

�,

1 h post-

1.5 h post-

2 hpost-

3 hpost-

4 h post-

CRP (�
Moderate 0.51 ± 0.26

0.57 ± O.'ll* 0.58 ± 0.28* 0.56 ± 0.26*

0.48 ± 0.23

0.52 ± 0.24

0.53 ± 0.26

0.49 ± 0.23

0.48 ± 0.20

0.51 ± 0.22

0.52 ± 0.21

Vigorous 0.68 ± 0.22

0.77 ± 0.24* 0.77 ± 0.25*

0.69 ± 0.22

0.66 ± 0. 19

0.66 ± 0.21

0.61 ± 0.19

0.61 ± 0.20

0.57 ± 0. 17

0.58 ± 0.17

0.55 ± 0. 17

3.23 ± 0.49*

3.31 ± 0.58

3.3 ± 0.59

3.1 ± 0.55

2.85 ± 0.56

2.89 ± 0.56

2.93 ± 0.44

2.72 ± 0.41

3.83 + 0.59*

3.59 + 0.59*

3.06 ±0,57

3.39 + 0.64

2.69 + 0.41

2.9 + 0.43

IL-6 (pwml)
Moderate 2.86 ± 0.57

2.92 ± 0.53

3.17 ± 0.51

Vigorous 2.69 ± 0.42

3.5 + 0.42*

4.59 ± 0.48* 4.76 + 0.53*t 4.66 + 0.58*

I t change frombefore exercise significantly different between vigorous and moderate exercise (p < 0.001)
* significantly different than before exercise (p < 0.05)
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Figure 1. CRP levels following moderate and vigorous exercise (Mean ± SE)
* significantly different from baseline
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Figure 2. IL-6 levels following moderate and vigorous exercise (Mean ± SE)
* significantly different than before exercise (p < 0.05)

t change from before exercise significantly different between vigorous and
moderate exercise (p < 0.001)

44

Individual CRP responses to moderate and vigorous exercise are shown in
Figures 3 and 4, respectively. Individual IL-6 responses to moderate and vigorous
exercise are shown in Figures 5 and 6, respectively.
The differences from baseline in IL-6 and CRP were calculated to
determine if there was an association between the increases found in these
markers. There was a significant association during vigorous exercise between
the increase in IL-6 during exercise and the increase in CRP immediately
following exercise (p = 0.003, r = 0.826).
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Figure 3. Individual CRP responses to moderate exercise
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Figure 4. Individual CRP responses to vigorous exercise
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Figure 5. Individual IL-6 responses to moderate exercise
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Figure 6. Individual IL-6 responses to vigorous exercise
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CHAPTER S
DISCUSSION
Inflammation, with respect to elevated CRP levels, has emerged as a probable risk
factor for CVD because of CRP's role in atherosclerotic plaque development. 35 A
chronically high level of CRP has been associated with an increased risk for developing
cardiovascular disease, and related to CVD risk factors such as obesity and
hypertension. 62 Circulating CRP level is also a significant predictor of myocardial
infarction, stroke, and death from coronary artery disease. 62
Acute increases in CRP may also be detrimental in terms of the impact it may
have on existing atherosclerotic plaque. CRP may trigger a myocardial infarction by
disrupting the caps of fibrous plaque. 1 8• 69 This cap breakdown could then ultimately lead
to vessel occlusion and a resulting cardiac event. Therefore, establishing the types of
events or conditions that could lead to acute elevations in CRP may help lower the risk of
suffering from an acute coronary syndrome.
The purpose of this study was to establish if acute bouts of moderate and vigorous
aerobic exercise result in an acute phase reaction during the time period when risk for MI
associated with exercise is greatest. When determining the optimal exercise prescription
for general and special populations, the degree of risk associated with the activity must be
taken into account. If vigorous exercise provides a greater inflammatory challenge, the
risks must be weighed when prescribing exercise.
Studies investigating the acute phase response to acute exercise have been
inconsistent in methodology. More specifically, the time frame for measurement has
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varied dramatically making it impossible to clarify the time course for changes in
inflammatory markers during and immediately following short bouts of moderate and
vigorous exercise. By waiting up to 24 hours to test for changes in CRP, these studies
may have failed to see any short-term acute changes. It is also difficult to establish
whether short moderate or vigorous bouts of exercise result in an acute phase response
during the time when risk for a cardiac event associated with activity is greatest since
many of the exercise events (i.e. extremely long, intense, or competitive events) that
information is based on would not be performed by the general population. 37
This study found that during the time period when the risk for an MI with exercise
is greatest, during activity and within 1-hour after activity, CRP increased 0.07 mg/1 with
moderate aerobic exercise and 0.09 mg/1 with vigorous aerobic exercise. This is the first
study to document the time course of the increase in CRP during an acute bout of aerobic
exercise. Strachan et al. found a significant increase in CRP immediately following
exercise, however, the activity consisted of a competitive running event, and not exercise
that would routinely be engaged in by an average person. 7° Feng et al. also found CRP to
be significantly elevated on average 0.11 mg/1 directly following a short maximal aerobic
bout. 19 Additional studies measuring CRP following competitive endurance events did
find much greater increases 'in CRP within 24 hours following exercise than what was
found with our study. 8 • 10• 34• 39' 44' 70 The CRP increase in these studies ranged from 0.3
mg/1 to 34.12 mg/1. More severe muscle damage or possible injury occurring with these
prolonged events and more maximal efforts may have led to a longer and much greater
acute phase response compared to that found with shorter exercise bouts used in this
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study. By performing multiple blood withdraws during and immediately following
exercise, we were able to document an increase in CRP during the time frame closely
associated with exercise-related cardiac events.
The average amplitude change in CRP over 24-hours in healthy individuals is
only 0.2 mg/1.43 Although our study and others finding an increase in CRP within 1 -hour
of exercise found increases less than the average daily fluctuation in healthy individuals,
the exact levels that are associated with causing a cardiac event, especially in diseased
populations, are unknown. Even small changes in CRP during or immediately following
exercise could be clinically significant for some individuals. Yip et al. reported that
patients had an average CRP level of 2. 7 + 2.3 mg/I within 6 hours of experiencing an
acute myocardial infraction. 85 Individual results for our study show that no individual
with a baseline level under 2.7 mg/I reached a CRP level that would be associated with a
MI at any point during moderate or vigorous exercise. Therefore, the absolute CRP
levels found during acute exercise in this study, in addition to the degree of change being
less than normal daily fluctuation, would lead one to believe that these types of exercise
bouts would not put a young healthy individual at an increased risk for a cardiac event.
Using levels of circulating CRP following exercise, however, may not be able to
establish whether exercise increases risk of a cardiac event. A greater increase in CRP
during or following exercise may occur locally in extrahepatic tissue, and therefore may
not be detectable in circulation during or immediately following exercise. Extrahepatic
tissues having the potential to locally produce CRP include peripheral mononuclear cells,
coronary artery smooth muscle cells, neurons, and kidney epithelial cells.77 Thus, local
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concentrations of CRP could be increased to much higher levels than circulating CRP
concentrations, making more CRP than is normally present available to act locally on
endothelial cells, monocytes, macrophages, and smooth muscle cells.
In addition, although the absolute number of individuals experiencing an acute
coronary syndrome during exercise is low, the consequences of this increased CRP may
actually go unnoticed in some individuals. Asymptomatic coronary plaque disruption has
been found in 9% of normal healthy persons and 22% of individuals with diabetes or
hypertension. 14 Therefore, the potential for this acute phase response to have adverse
effects on the body may go unseen.
Researchers have proposed that exercise-induced skeletal muscle damage triggers
the production of IL-6 by TNF-a and IL- l p. 46• 50 IL-6 is produced to initiate an
inflammatory response to repair damaged skeletal muscle, and is the principal stimulator
of CRP production. 27• 48• 52 This study found an increase in IL-6 following a 40-minute
bout of both moderate and vigorous exercise. Nieman et al. and Vassilakopoulos et al.
both found similar increases in IL-6 following moderate and vigorous exercise bouts of
similar duration.53• 76 Our methodology, however, allows us to concluded that an acute
bout of vigorous exercise results in a significantly greater inflammatory response than
moderate exercise. Although markers of muscle damage were not measured, the
association found between muscle damage and inflammation4' 57 would lead us to assume
that the vigorous exercise bout resulted in a higher degree of muscle damage than the
moderate bout of exercise.
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Previous research has found inconsistencies in the relationship between increases
in CRP and IL-6 following exercise. 17• 63• 64 IL-6 is the principal stimulator of CRP
production, 27 leading researchers to believe that increases in CRP would be associated
with increases in IL-6 during and following exercise. The only association found in this
study was between the increase in IL-6 during vigorous exercise and the increase in CRP
immediately following vigorous exercise. Because of potential lag time in CRP
stimulation, this staggered relationship would be expected between these two markers.
With regards to the lack of association at other time points for moderate and vigorous
exercise, the small and similar inc�eases occurring within individuals for both of these
markers may have made it difficult to establish any relationship. There is also the
possibility that factors other than IL-6, that are yet to be established, may be responsible
for stimulating CRP production during and following exercise.
This study is limited by the fact that only recreationally trained male cyclists were
examined. The inflammatory and acute phase response may be different in untrained
compared to trained individuals. 10• 40 Also, with females having an attenuated
inflammatory response to other forms of injury and trauma compared to males, 38 the
degree ,of the inflammatory response during and following exercise may differ between
genders. 44
To conclude, this study found that a significant acute phase response can occur
during and following moderate and vigorous exercise. The degree of elevation, though
statistically significant, would suggest that for young healthy cyclists, neither moderate
nor vigorous bouts of exercise lasting 45 minutes in duration would greatly elevate the
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risk of a cardiac event. However, it is important to define events or activities that have
the potential to increase this marker for certain at-risk populations, such as those with
coronary artery disease, since the exact increase in CRP that may elevate an individual's
risk for an acute coronary syndrome is unknown. Although there was no difference in the
acute phase response to moderate and vigorous exercise, the risk associated with activity
intensity may still differ. Moderate exercise in both healthy and coronary artery disease
patients has been found to have no significant effect on platelet activity that would be
involved in the events leading to a cardiac event. 79-81 Therefore, the effect that exercise
has on the total series of events leading to an acute coronary syndrome may make the risk
different between exercise intensities. More information is needed regarding the acute
phase response during exercise in different populations including training status, disease
states, and the effect of gender. It may also be important to study exercise of different
durations and modalities when determining the best exercise prescription for specific
populations. The increase in CRP that elevates an individual 's risk for plaque disruption
also needs to be established when trying to understand the risk associated with exercise.
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APPENDIX A
INFORMED CONSENT FORM
Investigators: Carolyn Albright and Dixie Thompson
Address:
The University of Tennessee
Department of Exercise, Sport, and Leisure Studies
1914 Andy Holt Ave.
Knoxville, TN 37996
Telephone: (865) 974-6040
Purpose
You are invited to participate in a research study. The purpose of this study is to characterize
the inflammatory response during and immediately following moderate and vigorous exercise.
The inflammatory response will be determined by measuring C-reactive protein (CRP) and
interleukin-6 (IL-6) levels during, and immediately following, exercise. If you give your
consent, you will be asked to perform the testing described below. The first testing day will
take approximately 1-hour. The second and third testing days will take approximately 6 hours.
You will complete a health history questionnaire prior to participation. All testing will be
performed in the Applied Physiology Laboratory in the Health, Physical Education, and
Recreation (HPER) building on the University of Tennessee campus.
Testing
1. The first testing day you will arrive to the laboratory having fasted and refrained from
structured exercise for 4 hours.
2. We will measure your height and weight. Your body fat will be determined using the Bod
Pod. During these tests you will wear either a swimsuit or spandex cycle shorts. You will sit
in the Bod Pod chamber for 2 one-minute trials while your body fat is determined. While in
the chamber you will be able to breathe normally and see your surroundings.
3. You will perform a maximal oxygen consumption test (V02max) on a cycle ergometer. For
this test you will breathe through a two-way breathing apparatus for respiratory gas
measurement. This apparatus does not disrupt your normal breathing. You will be asked to
choose a self-selected pedal speed between 60 and 80 rpm. The test will begin with a 2-minute
warm-up at a very light resistance. After two minutes the resistance will then be increased the
same amount each minute until you can no longer maintain your speed. Your heart rate will be
monitored with a heart rate monitor. The heart rate monitor is attached to a strap that is worn
around your chest, and your heart rate is transmitted to a watch.
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4. You will then come in on two separate occasions having refrained from all structured
exercise and alcohol consumption for 48-hours prior. The mornings that you come to the lab,
you can eat whatever you are comfortable eating before doing a normal cycling ride. On one
day you will perform a moderate cycle bout of exercise and on the other day you will perform
a vigorous cycle bout of exercise. When you arrive, a venous catheter will be placed into your
forearm. After resting for 15 minutes a baseline 5 ml blood sample will be taken. You will
then be fitted again with the two-way breathing apparatus. You will perform a 5-minute warm
up on the cycle ergometer, during which the work rate will gradually be increased to a level
considered moderate or vigorous. For the moderate bout you will ride at 50% of your V02max
and for the vigorous bout you will ride at 80% of your V02max. You will choose a comfortable
pedal speed to maintain throughout the exercise bout. After the 5-minute warm-up, you will
continue to cycle at the same work rate for 40 minutes. A 5 ml blood sample will be taken 30
minutes into the cycle bout and 0, 15, 30, 45, 60, 90, 120, 180, and 240 minutes post-exercise.
During the 4-hour period after cycling, you will remain in the HPER building and can perform
sedentary activities such as computer work or watching a movie. You will also be provided
with food during this time, or you can bring your own.
Potential Risks
The risks associated with exercising include abnormal blood pressure responses, musculo
skeletal injuries, dizziness, difficulty in breathing, and in rare cases heart attack or death. If
you experience any abnormal feelings while cycling such as chest pain or severe
breathlessness, stop cycling immediately. There are no known risks to the body fat test you
will complete. There is a slight risk of bruising and infection when blood is withdrawn.
Standard sterile procedures will be used to minimize the risk.
Benefits of Participation
From the results of your tests, you will be told your body fat percentage and V02max- These
tests would typically cost $100 if you were to schedule a regular testing appointment with our
laboratory.
Confidentiality
The information obtained from these tests will be treated as privileged and confidential and
will consequently not be released to any person without your consent. However, the
information will be used in research reports and presentations; however your name and other
identity will not be disclosed. All data will be stored in a locked filing cabinet in 136 HPER.
Informed consent forms will be stored for 3 years after completion of the study in HPER 340.
Contact Information
If you have questions at any time concerning the study or the procedures, or you experience
adverse effects as a result of participating in this study, you should contact your physician and
Carrie Albright at 974-6040. If you have questions about your rights as a participant, contact
Research Compliance Services of the Office of Research at (865) 974-3466.
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Right to Ask Questions and to Withdraw
You are free to decide whether or not to participate in this study and are free to withdraw from
the study at any time.

Before you sign this form, please ask questions about any aspects of the study, which are
unclear to you.
Consent
By signing this paper, I am indicating that I understand and agree to take part in this research
study.

Your signature

Date

Researcher's signature

Date
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APPENDIX B
HEALTH HISTORY QUESTIONNAIRE
NAME-------------

DATE

DATE OF BIRTH---------

AGE-----------

PHONE NUMBERS (HOME)_______(WORK)_______
e-mail address:-------------------------When is the best time to contact you?__________________
Please answer the following questions. This information will only be used for research
purposes and will not be made public. Please answer the following questions based on
physical exercise in which you regularly engage. This should not include daily work
activities such as walking from one office to another.
1. Do you regularly engage in exercise? Yes/No

If yes, please describe.

2. On average, how many times per week do you engage in exercise training?
0--1--2--3--4--5--6--7-3. On average, how many times per week do you engage in vigorous exercise training?
0--1--2--3--4--5--6--7-On average, how long is each of these vigorous exercise bouts: _______
5. How long have you been exercising at this level?
Less than 6 months
6 - 12 months
1 - 2 years
3 or more years
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6. Do you know of any reasons why you should not participate in physical activity:

MEDICAL HISTORY
Past History:
Have you ever been diagnosed with the following conditions? Please check the
appropriate column.
Rheumatic Fever
Heart Murmur
High Blood Pressure
Any heart problem
Lung Disease
Seizures
Irregular heart beat
Bronchitis
Emphysema
Diabetes
Asthma
Kidney Disease
Liver Disease
Severe Allergies
Orthopedic problems
Hyper- or Hypothyroidism
AIDS, hepatitis, or other
blood-home infectious disease

Yes
( )
( )
( )
( )
( )
( )
( )
( )
( )
( )
( )
( )
( )
( )
( )
( )
( )

No
( )
( )
( )
( )
( )
( )
( )
( )
( )
( )
( )
( )
( )
( )
( )
( )
( )

Don't Know
( )
( )
( )
( )
( )
( )
( )
( )
( )
( )
( )
( )
( )
( )
( )
( )
( )

Present Symptom Review:
Have you recently had any of the following symptoms? Please check if so.
Chest Pain
Shortness of Breath
Heart palpitations
Leg or ankle swelling
Coughing up blood
Low blood sugar
Feeling faint or dizzy
Leg numbness

(
(
(
(
(
(
(
(

)
)
)
)
)
)
)
)

Frequent Urination
(
Blood in Urine
(
Burning sensations
(
Severe headache
(
Blurred vision
(
(
Difficulty walking
Weakness in arm
(
Significant emotional problem (
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)
)
)
)
)
)
)
)

Are you taking any medications? Yes/No
If yes, please describe :_____________________
Do you smoke? Yes/No

If yes, how many per day?______

On average, how many alcoholic drinks do you consume per week?________

OTHER INFORMATION
Whom should we notify in ca.se of emergency?
Name
Address
Phone #
I have been given the opportunity to ask questions about any of the above items that were
unclear, and I have answered all questions completely and truthfully to the best of my
knowledge.
SIGNATURE-----------------DATE--------
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